Skip to Content
  • Revenues ($M)
    $9,968
  • Revenue Percent Change
    -41.3%
  • Profits ($M)
    $968
  • Profits Percent Change
    -61.2%
  • Assets ($M)
    $20,975
  • Employees
    49,400
  • Market Value — as of March 31, 2016 ($M)
    $22,601
  • Previous Rank
    185
  • Morning Consult Brand Index
    C

The biotech healthcare company makes devices and pharmaceuticals that treat hemophilia, immune disorders, infectious diseases, and kidney disease.

Company Info

Spun off Baxalta (2015 rank: 420), July 1, 2015.
CEO
Jose E. Almeida
Sector
Health Care
Industry
Medical Products and Equipment
HQ Location
Deerfield, IL
Websitehttp://www.baxter.com
Years on Fortune 500 List22
Employees49,400

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$9,968-41.3%
Profits ($M)$968-61.2%
Assets ($M)$20,975-
Total Stockholder Equity ($M)$8,846-
Market Value — as of March 31, 2016 ($M)$22,601-

Profit Ratios

Profit as % of Revenues9.7%
Profits as % of Assets4.6%
Profits as % of Stockholder Equity10.9%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)1.76
EPS % Change (from 2014)-61.4%
EPS % Change (5 year annual rate)-5.9%
EPS % Change (10 year annual rate)1.5%

Total Return

Total Return to Investors (2015)-2.7%
Total Return to Investors (5 year, annualized)9.3%
Total Return to Investors (10 year, annualized)8.7%